| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0062 | 1 |